Works matching AU Palandri, Francesca
Results: 101
Impact of Red Blood Cell Transfusions on Quality of Life for Patients With Myelofibrosis in the SIMPLIFY-1 and SIMPLIFY-2 Clinical Trials.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 357
- By:
- Publication type:
- Article
The "Vesicular Intelligence" Strategy of Blood Cancers.
- Published in:
- Genes, 2021, v. 12, n. 3, p. 416, doi. 10.3390/genes12030416
- By:
- Publication type:
- Article
Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 9, p. 3399, doi. 10.3390/ijms21093399
- By:
- Publication type:
- Article
Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.029
- By:
- Publication type:
- Article
Treatment Recommendations for Chronic Myeloid Leukemia.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2014, v. 6, n. 1, p. 1, doi. 10.4084/MJHID.2014.005
- By:
- Publication type:
- Article
MPN-332: Clinical Benefit of Pelabresib (Cpi-0610) in Combination with Ruxolitinib in JAK Inhibitor Treatment-Naïve Myelofibrosis Patients: Interim Efficacy Subgroup Analysis from Arm 3 of the MANIFEST Phase 2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S362, doi. 10.1016/S2152-2650(21)01833-4
- By:
- Publication type:
- Article
Poster: MPN-332: Clinical Benefit of Pelabresib (Cpi-0610) in Combination with Ruxolitinib in JAK Inhibitor Treatment-Naïve Myelofibrosis Patients: Interim Efficacy Subgroup Analysis from Arm 3 of the MANIFEST Phase 2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S234, doi. 10.1016/S2152-2650(21)01477-4
- By:
- Publication type:
- Article
Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-020-01776-8
- By:
- Publication type:
- Article
Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34<sup>+</sup> Cells.
- Published in:
- Mediators of Inflammation, 2018, p. 1, doi. 10.1155/2018/5974613
- By:
- Publication type:
- Article
Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 1, p. 67, doi. 10.1007/s00277-012-1556-5
- By:
- Publication type:
- Article
Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 8, p. 933, doi. 10.1007/s00277-010-1154-3
- By:
- Publication type:
- Article
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 123, doi. 10.1002/hon.2808
- By:
- Publication type:
- Article
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of JAK2<sup>V617F</sup> -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
New strategies in myelofibrosis: the evolving paradigm of disease pathogenesis, prognostication and treatment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01186
- By:
- Publication type:
- Article
The diagnostic role of Next Generation Sequencing in uncovering isolated splenomegaly: A case report.
- Published in:
- Hematology Reports, 2021, v. 13, n. 2, p. 1, doi. 10.4081/hr.2021.8814
- By:
- Publication type:
- Article
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI).
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 1, p. 189, doi. 10.1080/10428194.2021.1969388
- By:
- Publication type:
- Article
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048361
- By:
- Publication type:
- Article
Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.
- Published in:
- Expert Review of Hematology, 2014, v. 7, n. 3, p. 397, doi. 10.1586/17474086.2014.900432
- By:
- Publication type:
- Article
Eltrombopag second‐line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off‐treatment: results of a phase II, multicentre, prospective study.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 386, doi. 10.1111/bjh.17334
- By:
- Publication type:
- Article
Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID‐19) pandemic: selection criteria and patients' satisfaction.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 2, p. e48, doi. 10.1111/bjh.17208
- By:
- Publication type:
- Article
Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 888, doi. 10.1111/bjh.16462
- By:
- Publication type:
- Article
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 987, doi. 10.1111/bjh.15682
- By:
- Publication type:
- Article
Understanding how older age drives decision‐making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 424, doi. 10.1111/bjh.15668
- By:
- Publication type:
- Article
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 35, doi. 10.1111/bjh.15497
- By:
- Publication type:
- Article
Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 1, p. 160, doi. 10.1111/bjh.13758
- By:
- Publication type:
- Article
MYH9-related thrombocytopenia and intracranial bleedings: a complex clinical/surgical management and review of the literature.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 5, p. 729, doi. 10.1111/bjh.13324
- By:
- Publication type:
- Article
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 541, doi. 10.1111/bjh.13080
- By:
- Publication type:
- Article
Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role of MPL polymorphisms.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 1, p. 142, doi. 10.1111/bjh.12186
- By:
- Publication type:
- Article
Very elderly patients with essential thrombocythaemia: are they a separate category? A monocentric study on 118 patients older than 75 years.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 5, p. 676, doi. 10.1111/j.1365-2141.2011.08903.x
- By:
- Publication type:
- Article
Bleeding in essential thrombocythaemia: a retrospective analysis on 565 patients.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 2, p. 281, doi. 10.1111/j.1365-2141.2011.08858.x
- By:
- Publication type:
- Article
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1462, doi. 10.1002/ajh.27418
- By:
- Publication type:
- Article
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID‐19.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E470, doi. 10.1002/ajh.26732
- By:
- Publication type:
- Article
Second cancers in MPN: Survival analysis from an international study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 295, doi. 10.1002/ajh.25700
- By:
- Publication type:
- Article
Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E1, doi. 10.1002/ajh.25644
- By:
- Publication type:
- Article
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. E239, doi. 10.1002/ajh.25555
- By:
- Publication type:
- Article
Low-dose methotrexate as treatment of myeloproliferative neoplasms: Proof of principle of clinical activity.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. E329, doi. 10.1002/ajh.24406
- By:
- Publication type:
- Article
Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. E267, doi. 10.1002/ajh.24310
- By:
- Publication type:
- Article
Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. E267, doi. 10.1002/ajh.24310
- By:
- Publication type:
- Article
The choice of second-line therapy in steroid-resistant immune thrombocytopenia: Role of platelet kinetics in a single-centre long-term study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. 1047, doi. 10.1002/ajh.23823
- By:
- Publication type:
- Article
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: Safety of cytoreductive therapy.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 4, p. 215, doi. 10.1002/ajh.21360
- By:
- Publication type:
- Article
Partial splenic embolization preceding splenectomy, in a case of refractory immune thrombocytopenic purpura.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 6, p. 520, doi. 10.1002/ajh.21172
- By:
- Publication type:
- Article